Eikon Therapeutics, Inc. (EIKN)
NASDAQ: EIKN · Real-Time Price · USD
14.91
+0.53 (3.69%)
At close: Mar 9, 2026, 4:00 PM EDT
14.92
+0.01 (0.07%)
After-hours: Mar 9, 2026, 4:45 PM EDT
Eikon Therapeutics Market Cap
Eikon Therapeutics has a market cap or net worth of $804.91 million as of March 9, 2026.
Market Cap
804.91M
Enterprise Value
669.78M
1-Year Change
n/a
Ranking
Category
Stock Price
$14.91
Market Cap Chart
Since the IPO on February 5, 2026, Eikon Therapeutics's market cap has decreased from $971.72M to $804.91M, a decrease of -17.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 776.29M | -1.10% |
| Mar 5, 2026 | 784.93M | -4.09% |
| Mar 4, 2026 | 818.40M | 9.86% |
| Mar 3, 2026 | 744.98M | -7.26% |
| Mar 2, 2026 | 803.29M | 7.98% |
| Feb 27, 2026 | 743.90M | 1.03% |
| Feb 26, 2026 | 736.35M | -8.39% |
| Feb 25, 2026 | 803.83M | -0.07% |
| Feb 24, 2026 | 804.37M | 2.97% |
| Feb 23, 2026 | 781.15M | -2.76% |
| Feb 20, 2026 | 803.29M | -4.00% |
| Feb 19, 2026 | 836.76M | -4.67% |
| Feb 18, 2026 | 877.79M | 3.44% |
| Feb 17, 2026 | 848.63M | 4.45% |
| Feb 13, 2026 | 812.46M | 1.48% |
| Feb 12, 2026 | 800.59M | 2.35% |
| Feb 11, 2026 | 782.23M | 6.62% |
| Feb 10, 2026 | 733.65M | -6.60% |
| Feb 9, 2026 | 785.47M | 0.34% |
| Feb 6, 2026 | 782.77M | -19.44% |
| Feb 5, 2026 | 971.72M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BridgeBio Oncology Therapeutics | 833.94M |
| Xencor | 830.19M |
| KalVista Pharmaceuticals | 820.37M |
| Omeros | 818.19M |
| MapLight Therapeutics | 807.80M |
| MannKind | 804.14M |
| CytomX Therapeutics | 792.96M |
| Kura Oncology | 791.43M |